Related references
Note: Only part of the references are listed.Multilocular sinonasal malignant melanoma: a poor prognostic subgroup?
O. Stanimirov Rossi et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2015)
An Aggressive Hypoxia Related Subpopulation of Melanoma Cells is TRP-2 Negative
Daniela Lenggenhager et al.
TRANSLATIONAL ONCOLOGY (2014)
KIT, NRAS and BRAF mutations in sinonasal mucosal melanoma: a study of 56 cases
A. Zebary et al.
BRITISH JOURNAL OF CANCER (2013)
Safety and Tumor Responses with Lambrolizumab (Anti-PD-1) in Melanoma
Omid Hamid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Sinonasal, genital and acrolentiginous melanomas show distinct characteristics of KIT expression and mutations
Nicola L. Schoenewolf et al.
EUROPEAN JOURNAL OF CANCER (2012)
Mucosal Melanoma: Pathogenesis, Clinical Behavior, and Management
Michael A. Postow et al.
CURRENT ONCOLOGY REPORTS (2012)
Detecting BRAF Mutations in Formalin-Fixed Melanoma: Experiences with Two State-of-the-Art Techniques
Nicola L. Schoenewolf et al.
CASE REPORTS IN ONCOLOGY (2012)
BORIS Binding to the Promoters of Cancer Testis Antigens, MAGEA2, MAGEA3, and MAGEA4, Is Associated with Their Transcriptional Activation in Lung Cancer
Sheetal Bhan et al.
CLINICAL CANCER RESEARCH (2011)
Expression of MAGE-C1/CT7 and MAGE-C2/CT10 Predicts Lymph Node Metastasis in Melanoma Patients
Alessandra Curioni-Fontecedro et al.
PLOS ONE (2011)
OUTCOME OF SINONASAL MELANOMA: CLINICAL EXPERIENCE AND REVIEW OF THE LITERATURE
Thomas N. Roth et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2010)
Fine analysis of spontaneous MAGE-C1/CT7-specific immunity in melanoma patients
Natko Nuber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Frequent expression of the novel cancer testis antigen MAGE-C2/CT-10 in hepatocellular carcinoma
Marc-Oliver Riener et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
MAGE-C1/CT-7 expression in plasma cell myeloma: Sub-cellular localization impacts on clinical outcome
M. Tinguely et al.
CANCER SCIENCE (2008)
Epigenetic control of MAGE gene expression by the KIT tyrosine kinase
Bing Yang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
A new tumor-specific antigen encoded by MAGE-C2 and presented to cytolytic T lymphocytes by HLA-B44
Daniele Godelaine et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Tumor antigen expression in melanoma varies according to antigen and stage
C Barrow et al.
CLINICAL CANCER RESEARCH (2006)
Cancer/testis antigens, gametogenesis and cancer
AJG Simpson et al.
NATURE REVIEWS CANCER (2005)
The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation
AA Jungbluth et al.
BLOOD (2005)
Expression of cancer/testis (CT) antigens in Chinese hepatocellular carcinoma and its correlation with clinical parameters
JR Peng et al.
CANCER LETTERS (2005)
Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2′-deoxycytidine
L Sigalotti et al.
CANCER RESEARCH (2004)
Melanoma or not?: Cancer testis antigens may help
M Lüftl et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
Ct7 (MAGE-CI) antigen expression in normal and neoplastic tissues
AA Jungbluth et al.
INTERNATIONAL JOURNAL OF CANCER (2002)